Inger Kull
Biographic Data
| ID | 5470462 |
|---|---|
| NAME | Inger Kull |
| GIVEN NAMES | Inger |
| FAMILY NAME | Kull |
| SIGNATURE | KULL I |
| AFFILIATIONS | Stockholm South General Hospital |
| ORCID | 0000-0001-6096-3771 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Post Covid-19 among young adults– prevalence and associations with general health, stress, and lifestyle factors
Almost 4% of young adults with previous self-reported COVID-19 had ongoing symptoms of PCC three years after the onset of the pandemic. This group reported poorer health and more adverse changes in lifestyle factors than participants without PCC. Targeted healthcare interventions for young adults with PCC are warranted
Home Immunization with Palivizumab-A Randomized Pilot Study Describing Safety Aspects and Parents’ Preferences
Among prematurely born infants and newborns with chronic conditions, a respiratory syncytial virus (RSV) infection may cause (re-)admission and later respiratory complications. Therapeutic protection is possible with monthly injections of a specific monoclonal antibody, palivizumab, during RSV season. Standard care is giving up to five injections in clinic-based settings. Immunization at home could be an alternative to standard care for vulnerabl…
Changes in lifestyle, adiposity, and cardiometabolic markers among young adults in Sweden during the Covid-19 pandemic
Lifestyle factors, adiposity and cardiometabolic markers may have been adversely affected among young adults in Sweden during the COVID-19 pandemic compared with the preceding years. Targeted public health measures to reduce obesity and improve healthy lifestyle are important to prevent future non-communicable diseases
No prominent works on this page.
Home Immunization with Palivizumab-A Randomized Pilot Study Describing Safety Aspects and Parents’ Preferences
Among prematurely born infants and newborns with chronic conditions, a respiratory syncytial virus (RSV) infection may cause (re-)admission and later respiratory complications. Therapeutic protection is possible with monthly injections of a specific monoclonal antibody, palivizumab, during RSV season. Standard care is giving up to five injections in clinic-based settings. Immunization at home could be an alternative to standard care for vulnerabl…
Changes in lifestyle, adiposity, and cardiometabolic markers among young adults in Sweden during the Covid-19 pandemic
Lifestyle factors, adiposity and cardiometabolic markers may have been adversely affected among young adults in Sweden during the COVID-19 pandemic compared with the preceding years. Targeted public health measures to reduce obesity and improve healthy lifestyle are important to prevent future non-communicable diseases
Post Covid-19 among young adults– prevalence and associations with general health, stress, and lifestyle factors
Almost 4% of young adults with previous self-reported COVID-19 had ongoing symptoms of PCC three years after the onset of the pandemic. This group reported poorer health and more adverse changes in lifestyle factors than participants without PCC. Targeted healthcare interventions for young adults with PCC are warranted
Environmental health (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Population (3 works) · Cohort (2 works) · Cohort study (2 works) · Coronavirus disease 2019 (COVID-19 (2 works) · Demography (2 works) · Demography (2 works) · Disease (2 works)